Rajaa Aziz Jabbar¹ and Riyadh Waheed AL. Esawi²

Department of Radiology, College of Medicine, University of Kufa, Iraq

Received: Oct 3, 2023/ Revised: Oct 29, 2023/Accepted: Oct 31, 2023

(✉) Corresponding Author: Rajaa Aziz Jabbar

Abstract

Fluorodeoxyglucose (FDG) positron emission’s significance in lymphoma is currently growing. Previous research and literature have shown that FDG-PET has a higher diagnostic and staging accuracy than CT-scan for lymphoma. FDG-PET still has a drawback in the anatomical localization of the pathology. This study’s goal is to evaluate the effectiveness of Positron Emission Tomography-Computed Tomography (PET-CT) for the initial staging of lymphoma. This prospective study involved 100 patients (39 females and 61 males) with an age rate from 3 to 69 years old (average 38 years). All patients were referred for tomography–computed tomography–computed tomography PET-CT- scan which proved by biopsy as Lymphoma for initial staging with Fluorine-18 fluorodeoxyglucose–Positron Emission Tomography–Computed Tomography Scan. The median patient age 38 (range 3 – 69) years, Males dominant represented 61%. Among the studied group, 60 patients had Hodgkin lymphoma (HL), and the remaining 40% with non-Hodgkin lymphoma (NHL) The mean SUV values were significantly increased with the advancing stage, (P. value 0.008). ROC analysis revealed that SUV was a good predictor of an advanced stage of malignancy, at an optimal cutoff point of ≥ 3 (SUV).

Keywords:  FDG-PET, Lymphoma, PET-CT, Initial staging, Standardized Uptake Value.

References

Buchpiguel, C. A. (2011). Current status of PET/CT in the diagnosis and follow up of lymphomas. Revista Brasileira De Hematologia E Hemoterapia, 33(2), 140–147.

https://doi.org/10.5581/1516-8484.20110035

Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014). Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. Journal of Clinical Oncology, 32(27), 3059–3067.

https://doi.org/10.1200/jco.2013.54.8800

Frampas, E. (2013). Lymphomas: Basic points that radiologists should know. Diagnostic and Interventional Imaging, 94(2), 131–144.

https://doi.org/10.1016/j.diii.2012.11.006

Freudenberg, L. S., Antoch, G., Schott, P., Beyer, T., Jentzen, W., Muller, S. P., Debatin, J. F. (2004). FDG-PET/CT in re-staging of patients with lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 31(3), 325–329.

https://doi.org/10.1007/s00259-003-1375-y

Gabus, R., Pavlovsky, A., Eleta, M., Skrypets, T., Kryachok, I., Novosad, O. & Chauvie, S. (2021). PET/CT Imaging of Lymphoma Outside the Western World. Exon Publications, 117-139.

https://doi.org/10.36255/exon-publications.lymphoma.2021.pet-imaging

Kim, H. J., Lee, R., Choi, H., Paeng, J. C., Cheon, G. J., Lee, D. S., Kang, K. W. (2018). Application of Quantitative Indexes of FDG PET to Treatment Response Evaluation in Indolent Lymphoma. Nuclear Medicine and Molecular Imaging, 52(5), 342–349.

https://doi.org/10.1007/s13139-018-0543-8

Kwee, T. C., Kwee, R. M., & Nievelstein, R. A. J. (2008). Imaging in staging of malignant lymphoma: a systematic review. Blood, 111(2), 504–516.

https://doi.org/10.1182/blood-2007-07-101899

Naguib, M. M., Botros, S. M., Louka, A. L., & Hussein, R. S. (2021). Role of PET/CT in initial evaluation of lymphoma patients. Egyptian Journal of Radiology and Nuclear Medicine, 52(1).

https://doi.org/10.1186/s43055-021-00670-3

Specialty Imaging: Postoperative SpineRossJeffrey Philadelphia, PA: Wolters Kluwer Lippincott Williams & Wilkins, 2012. ISBN 978-1-931884-89-1. Hardcover, $249.00; pp 400. (2012). Radiology, 265(3), 694–694.

https://doi.org/10.1148/radiol.12124043

Yoo, K. H. (2022). Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT. Blood Research, 57(S1), S75–S78.

https://doi.org/10.5045/br.2022.2022055

How to cite this article

Jabbar, R. A., Al-Esawi, R. W. and Ghaith, R. F. (2023). The role of PET-CT-Scan in the initial staging of Lymphoma. Science Archives, Vol. 4(4), 286-290.

https://doi.org/10.47587/SA.2023.4407

Licence                  Article Metadata

This work is licensed under a Creative Commons Attribution 4.0 International License.

[pdf_attachment file="1" name="View Details"]